Detection Kits for Hematopoietic Disease Biomarkers

Hematopoietic diseases encompass a broad spectrum of disorders affecting the production and function of blood cells, including coagulation factors essential for hemostasis. Among these, hemophilia A and B, caused by deficiencies in coagulation Factor VIII and Factor IX respectively, represent the most well-known inherited bleeding disorders, affecting approximately 1 in 5,000 male births for hemophilia A and 1 in 30,000 for hemophilia B. Factor VII deficiency, while rarer, presents with similar bleeding manifestations and requires accurate diagnostic assessment. The precise quantification of these coagulation factors is fundamental for disease diagnosis, severity classification, and monitoring of replacement therapy. Creative Diagnostics offers comprehensive ELISA-based solutions to support these critical needs, including the Human Coagulation Factor VIII Total Antigen ELISA Kit, Human F7 ELISA Kit, and Human F9 ELISA Kit, enabling accurate quantification of key coagulation factors to advance research into bleeding disorders.